610 Loss of the Tumor Suppressor Merlin as a Potential Predictive Biomarker of Clinical Activity for the Oral, Focal Adhesion Kinase (FAK) Inhibitor GSK2256098 in Pts with Recurrent Mesothelioma Conference Paper uri icon

authors

  • Soria, JC
  • Plummer, R
  • Ranson, M
  • Gan, H
  • Arkenau, HT
  • Zalcman, G
  • Blagden, S
  • Evans, TRJ
  • Peddareddigari, V
  • Mazumdar, J
  • Murray, S
  • Gibson, D
  • Fleming, RA
  • Auger, K
  • Millward, M

publication date

  • November 2012